Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Esam Azhar and Markus Maeurer.
Esam Azhar
Connection Strength
0.909
Markus Maeurer
  1. Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants. Int J Infect Dis. 2020 Sep; 98:454-459.
    View in: PubMed
    Score: 0.223
  2. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies. Int J Infect Dis. 2020 Jul; 96:431-439.
    View in: PubMed
    Score: 0.221
  3. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020 02 22; 395(10224):e35-e36.
    View in: PubMed
    Score: 0.216
  4. Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections. Int J Infect Dis. 2015 Nov; 40:71-4.
    View in: PubMed
    Score: 0.159
  5. Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB". Int J Infect Dis. 2018 03; 68:122-124.
    View in: PubMed
    Score: 0.048
  6. Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential. Int J Infect Dis. 2016 Jun; 47:5-9.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.